X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (243) 243
Book Chapter (17) 17
Patent (15) 15
Publication (11) 11
Book / eBook (3) 3
Book Review (2) 2
Conference Proceeding (1) 1
Presentation (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (140) 140
endocrinology & metabolism (101) 101
female (86) 86
index medicus (74) 74
osteoporosis (61) 61
male (59) 59
middle aged (55) 55
animals (53) 53
aged (52) 52
bisphosphonates (40) 40
mice (36) 36
diphosphonates - therapeutic use (34) 34
adult (31) 31
postmenopausal women (30) 30
fractures (28) 28
orthopedics (26) 26
bone density - drug effects (22) 22
diphosphonates - pharmacology (22) 22
alendronate (21) 21
osteoporosis - drug therapy (21) 21
women (21) 21
aged, 80 and over (20) 20
bone resorption (20) 20
density (19) 19
bone density conservation agents - therapeutic use (18) 18
drug therapy (18) 18
rheumatology (18) 18
bone mineral density (17) 17
bone resorption - drug therapy (17) 17
bone-mineral density (17) 17
bones (17) 17
postmenopausal osteoporosis (17) 17
risk factors (17) 17
sclerostin (17) 17
bone (16) 16
bone density (16) 16
genetic markers (16) 16
medicine & public health (16) 16
radiography (16) 16
diphosphonates (15) 15
diphosphonates - administration & dosage (15) 15
human necessities (15) 15
hygiene (15) 15
medical or veterinary science (15) 15
preparations for medical, dental, or toilet purposes (15) 15
acyclic, carbocyclic or heterocyclic compounds containingelements other than carbon, hydrogen, halogen, oxygen, nitrogen,sulfur, selenium or tellurium (14) 14
bone and bones - drug effects (14) 14
bone neoplasms - secondary (14) 14
chemistry (14) 14
metallurgy (14) 14
organic chemistry (14) 14
diphosphonates - adverse effects (13) 13
endocrinology (13) 13
in-vitro (13) 13
osteoporosis, postmenopausal - drug therapy (13) 13
pamidronate (13) 13
van-buchem-disease (13) 13
denosumab (12) 12
bisphosphonate (11) 11
bone density conservation agents - adverse effects (11) 11
bone morphogenetic proteins - metabolism (11) 11
bone turnover (11) 11
care and treatment (11) 11
diphosphonates - pharmacokinetics (11) 11
dose-response relationship, drug (11) 11
mineral density (11) 11
parathyroid-hormone (11) 11
research (11) 11
resorption (11) 11
sost gene (11) 11
treatment outcome (11) 11
vertebral fractures (11) 11
zoledronic acid (11) 11
apd (10) 10
bmp antagonist (10) 10
bone formation (10) 10
carcinoma (10) 10
fracture (10) 10
fractures, bone - prevention & control (10) 10
health aspects (10) 10
osteitis deformans - drug therapy (10) 10
pregnancy (10) 10
protein (10) 10
time factors (10) 10
bone and bones - pathology (9) 9
breast neoplasms - pathology (9) 9
calcium - metabolism (9) 9
growth (9) 9
risedronate (9) 9
risk (9) 9
sclerosteosis (9) 9
therapy (9) 9
administration, oral (8) 8
adolescent (8) 8
analysis (8) 8
bone and bones - metabolism (8) 8
bone density - physiology (8) 8
bone density conservation agents - administration & dosage (8) 8
bone remodeling - physiology (8) 8
cells, cultured (8) 8
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Bone, ISSN 8756-3282, 2014, Volume 68, pp. 167 - 168
Journal Article
Journal Article
Nature Reviews Endocrinology, ISSN 1759-5029, 10/2018, Volume 14, Issue 10, pp. 605 - 623
The WNT signalling pathway is a key regulator of bone metabolism, particularly bone formation, which has helped to define the role of osteocytes - the most... 
ABDOMINAL AORTIC CALCIFICATION | MINERAL DENSITY | VASCULAR CALCIFICATION | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | CARDIOVASCULAR-DISEASE | SERUM SCLEROSTIN | CHRONIC KIDNEY-DISEASE | POSTMENOPAUSAL WOMEN | SCLEROSTIN-ANTIBODY TREATMENT | RAT MODEL
Journal Article
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, ISSN 0884-0431, 08/2019
Cessation of denosumab treatment is associated with increases in bone turnover above baseline values and rapid bone loss. We investigated the efficacy of... 
Journal Article
JOURNAL OF BONE AND MINERAL RESEARCH, ISSN 0884-0431, 12/2014, Volume 29, Issue 12, pp. 2527 - 2528
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 08/2019, Volume 104, Issue 12, pp. 6069 - 6078
Fibrous dysplasia/McCune Albright syndrome (FD/MAS) is a rare bone disorder commonly treated with bisphosphonates but clinical and biochemical responses may be... 
Journal Article
Drugs, ISSN 0012-6667, 07/2015, Volume 75, Issue 10, pp. 1049 - 1049
Bone remodeling, the fundamental process for bone renewal, is targeted by treatments of osteoporosis to correct the imbalance between bone resorption and bone... 
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 12/2017, Volume 32, Issue 12, pp. 2375 - 2380
Journal Article
Best Practice & Research Clinical Endocrinology & Metabolism, ISSN 1521-690X, 10/2018, Volume 32, Issue 5, pp. 657 - 668
Journal Article
Annals of the Rheumatic Diseases, ISSN 0003-4967, 01/2011, Volume 70, pp. i119 - i122
In recent years, study of rare bone diseases has led to the identification of signalling pathways that regulate bone formation and provided targets for the... 
Journal Article
European Journal of Endocrinology, ISSN 0804-4643, 06/2017, Volume 176, Issue 6, p. 677
Objective To test the hypothesis that rebound of bone remodeling is responsible for clinical vertebral fractures reported in a few patients with osteoporosis... 
Vertebrae | Bone remodelling | MiRNA | Injection | Gene expression | Patients | Post-menopause | Osteoclastogenesis | Osteoporosis | Fractures | Collagen | Osteoclasts | Biochemical characteristics | Biochemical markers
Journal Article
NATURE REVIEWS ENDOCRINOLOGY, ISSN 1759-5029, 12/2016, Volume 12, Issue 12, pp. 691 - 691
In a recent study by Cosman and colleagues, romosozumab - a humanized monoclonal antibody targeting sclerostin - is shown to reduce the risk of vertebral and... 
TRIAL | WOMEN | FRACTURES | POSTMENOPAUSAL OSTEOPOROSIS | DENOSUMAB | ENDOCRINOLOGY & METABOLISM
Journal Article
NATURE REVIEWS ENDOCRINOLOGY, ISSN 1759-5029, 02/2015, Volume 11, Issue 2, pp. 69 - 70
In 2014, two phase II clinical studies reported rapid, impressive increases in BMD in women with low bone mass who were treated with sclerostin inhibitors for... 
TRIAL | WOMEN | MINERAL DENSITY | SCLEROSTIN ANTIBODY | POSTMENOPAUSAL OSTEOPOROSIS | DENOSUMAB | ENDOCRINOLOGY & METABOLISM | TERIPARATIDE | STRENGTH | Prevention | Osteoporosis | Medical research | Care and treatment | Fractures | Bone regeneration | Medicine, Experimental | Research
Journal Article
Bone, ISSN 8756-3282, 11/2007, Volume 41, Issue 5, p. S2
Journal Article
Bone, ISSN 8756-3282, 11/2007, Volume 41, Issue 5, p. S2
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.